Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 2/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.31 |
| ▸ | CCR8 | P51685 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7904164 | 0.75 | CCR1 (0.37) | DYRK1ACCR1CCR5CCR8NOS3 | |
| SCHEMBL24393074 | 0.62 | EGFR (0.40) | CCR1CCR5CCR8 | |
| SCHEMBL1243360 | 0.61 | — | — | |
| SCHEMBL6842125 | 0.60 | DYRK1A (0.49) | DYRK1AGSK3B | |
| SCHEMBL8374076 | 0.58 | DYRK1A (0.39) | DYRK1AGSK3B | |
| SCHEMBL8618825 | 0.58 | — | — | |
| SCHEMBL24917666 | 0.56 | PIK3C3 (0.35) | DYRK1ANOS3NOS2 | |
| SCHEMBL23176063 | 0.55 | DYRK1A (0.34) | DYRK1A | |
| SCHEMBL23175771 | 0.54 | — | — | |
| SCHEMBL23589214 | 0.54 | EGFR (0.37) | CCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546406-B2 | Heterocyclic compounds as metap-2 inhibitors | MERCK PATENT GMBH (DE) | 2013-10-01 | — | — | US | disclosed |
| WO-2010083870-A1 | NOVEL HETEROCYCLIC COMPOUNDS FOR USE AS METAP-2 INHIBITORS | MERCK PATENT GMBH (DE) | 2010-07-29 | — | — | WO | disclosed |